Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 553-564 of 1,909
Drug study icon
CompletedNCT00845988

Metabolic Effects of Switching to Aripiprazole in people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Seongnam-si
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
South Korea
Sponsor
Seoul National University Hospital
Condition
Bipolarity
Behavioral study icon
CompletedNCT03249857

Sensorimotor Compatibility Effects in Bipolarity.

This summary needs review. Please check the official study record and contact the research team for details.

In Saint-Etienne
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2012-004334-42

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients with Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Hungary
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Hungary
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-004167-27

A Phase 3, randomized, 6-month, double blind trial in subjects with Bipolarity type I to evaluate the continued safety and maintenance of effect of Ziprasidone plus a mood stabilizer (vs placebo p...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Germany, Italy, Spain, ...
Sponsor
Pfizer, S.A.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2004-003781-14

A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolarity type I,...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Austria, Slovakia, Spain
Sponsor
Johnson & Johnson Pharmaceutical Research and Development
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2009-017581-22

Cognitive impairment in Bipolarity treated with aripiprazole

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Germany
Sponsor
Department of Psychiatry and Psychotherapy, Charity University Medicine
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-002134-35

EXTENSION STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN THE RECURRENCE PREVENTION OF Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Austria, Czechia, Germany, ...
Sponsor
Bial - Portela & Cª, S.A.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2004-000589-11

Protocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Hungary
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Hungary
Sponsor
ELI LILLY and COMPANY
Condition
Bipolarity
Drug study icon
Not recruitingEUCTR 2009-016041-25

A Long-Term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Germany, Hungary, Spain
Sponsor
Forest Research Institute, Inc.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.